Advanced Life Sciences Cancels Annual Meeting of Shareholders

CHICAGO, May 20, 2011 /PRNewswire/ -- Advanced Life Sciences Holdings, Inc. (OTCBB: ADLS.OB), announced today that it has cancelled its Annual Meeting of Shareholders, which was previously scheduled to take place on Tuesday, May 24, 2011.  

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases.  On May 5, 2011, Advanced Life Sciences announced that it had suspended operations and terminated its staff due to its severe lack of liquidity.

SOURCE Advanced Life Sciences Holdings, Inc.

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spin-out company SpringWorks has lost president and founder Lara Sullivan, M.D. who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.